<--- Back to Details
First PageDocument Content
Signal transduction / Proteins / Cell signaling / Amines / Quinazolines / Erlotinib / Phosphoinositide 3-kinase / STAT3 / AKT / Biology / Chemistry / Cell biology
Date: 2013-10-29 15:04:53
Signal transduction
Proteins
Cell signaling
Amines
Quinazolines
Erlotinib
Phosphoinositide 3-kinase
STAT3
AKT
Biology
Chemistry
Cell biology

Module 2: Systems Engineering (M2D6) • • • •

Add to Reading List

Source URL: openwetware.org

Download Document from Source Website

File Size: 3,74 MB

Share Document on Facebook

Similar Documents

Biology / Cell biology / Biochemistry / Signal transduction / Cell signaling / Molecular biology / Tyrosine kinase receptors / Phosphodiesterase / Cyclic nucleotide / CGMP-specific phosphodiesterase type 5 / Autocrine signalling / STAT3

Microsoft Word - abstracts_compiled.doc

DocID: 1rn3E - View Document

Transcription factors / Induced stem cells / Proteins / Epigenetics / Developmental biology / NTERA-2 / Epigenetics in stem-cell differentiation / Glial fibrillary acidic protein / Cellular differentiation / DNA methylation / MECP2 / Stem cell

Interplay between SIN3A and STAT3 Mediates Chromatin Conformational Changes and GFAP Expression during Cellular Differentiation Pei-Yi Cheng1,2, Yu-Ping Lin2, Ya-Ling Chen3, Yi-Ching Lee4, Chia-Chen Tai4, Yi-Ting Wang5,

DocID: 1oyVz - View Document

Stem Cell Reports Ar ticle Local BMP-SMAD1 Signaling Increases LIF Receptor-Dependent STAT3 Responsiveness and Primed-to-Naive Mouse Pluripotent Stem Cell Conversion Frequency

DocID: 1l4Xy - View Document

B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway

DocID: 1e111 - View Document

Ribbon symbolism / Cancer treatments / Triple-negative breast cancer / Chemotherapy / TNBC / Breast cancer treatment / Medicine / Oncology / Breast cancer

Award ID: DP150069 Project Title: Oral Stat3 Inhibitor as Targeted Treatment for Triple-Negative Breast Cancer Award Mechanism:

DocID: 1am5c - View Document